π©Ί 2025 ACS Management Guidelines Summary π
β’ π©Έ DAPT recommended: Ticagrelor or prasugrel preferred over clopidogrel in PCI patients.
β’ π― Lipid management: High-intensity statins + ezetimibe; PCSK9 inhibitors if LDL-C β₯70 mg/dL.
β’ π¬ Invasive approach: Recommended for intermediate/high-risk NSTE-ACS; radial access preferred for PCI.
β’ π Revascularization: Complete revascularization advised for STEMI/NSTE-ACS; intracoronary imaging for complex lesions.
β’ β€οΈ Cardiogenic shock: Emergency PCI for culprit vessel; microaxial flow pump may help select patients.
β’ π₯ Secondary prevention: Lipid monitoring, cardiac rehab, and long-term risk reduction strategies are key.